Latest News
Natera, Inc.
- Natera stock initiated with buy rating at Roth/MKM on oncology outlook
- Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October
- Form 144 NATERA For: 18 October By Investing.com
- Natera Gains 118.1% in a Year: What's Driving the Rally?
- Natera Signatera: The Best Inventions of 2026
- FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
- Catalyst Funds’ David Miller: Natera can grow at exponential margins for years to come
- FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
- Natera stock falls nearly 6% as sellers override momentum despite strong phase III trial news
- Why is Natera stock sliding today?
- Form 4 Natera Inc For: 2 October By Investing.com
- Final Trades: Hewlett Packard, Natera and UnitedHealth
Headlines from the last 30 days, linking to the original publishers. See all market news →